SlideShare a Scribd company logo
1 of 6
Guías prevención CV Alberto Esteban Fernández
2019 ACC/ AHA GUIDELINE
ON THE PRIMARY PREVENTION
OF CARDIOVASCULAR DISEASE
Guías prevención CV Alberto Esteban Fernández
Guías prevención CV Alberto Esteban Fernández
Top 10 Take – Home Messages
for the Primary Prevention
of Cardiovascular Disease
Guías prevención CV Alberto Esteban Fernández
1. The most important way to prevent atherosclerotic vascular disease, heart failure, and
atrial fibrillation is to promote a healthy lifestyle throughout life.
2. A team-based care approach is an effective strategy for the prevention of
cardiovascular disease. Clinicians should evaluate the social determinants of health
that affect individuals to inform treatment decisions.
3. Adults who are 40 to 75 years of age and are being evaluated for cardiovascular
disease prevention should undergo 10-year atherosclerotic cardiovascular disease
(ASCVD) risk estimation and have a clinician–patient risk discussion before starting on
pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In
addition, assessing for other risk-enhancing factors can help guide decisions about
preventive interventions in select individuals, as can coronary artery calcium scanning.
Guías prevención CV Alberto Esteban Fernández
4. All adults should consume a healthy diet that emphasizes the intake of vegetables,
fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the
intake of trans fats, processed meats, refined carbohydrates, and sweetened
beverages. For adults with overweight and obesity, counseling and caloric restriction
are recommended for achieving and maintaining weight loss.
5. Adults should engage in at least 150 minutes per week of accumulated moderate-
intensity physical activity or 75 minutes per week of vigorous-intensity physical activity.
6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary
habits and achieving exercise recommendations, are crucial. If medication is indicated,
metformin is first-line therapy, followed by consideration of a sodium-glucose
cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist.
Guías prevención CV Alberto Esteban Fernández
7. All adults should be assessed at every healthcare visit for tobacco use, and those who
use tobacco should be assisted and strongly advised to quit.
8. Aspirin should be used infrequently in the routine primary prevention of ASCVD
because of lack of net benefit.
9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with
elevated lowdensity lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes
mellitus, who are 40 to 75 years of age, and those determined to be at sufficient
ASCVD risk after a clinician–patient risk discussion.
10. Nonpharmacological interventions are recommended for all adults with elevated blood
pressure or hypertension. For those requiring pharmacological therapy, the target
blood pressure should generally be <130/80 mm Hg.

More Related Content

What's hot

His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...
His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...
His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...vaibhavyawalkar
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEFDuke Heart
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsahvc0858
 
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approachDyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approachDr Vivek Baliga
 
2023 AHAACC Guideline.pptx
2023 AHAACC Guideline.pptx2023 AHAACC Guideline.pptx
2023 AHAACC Guideline.pptxAadhi55
 
Transition study and Pioneer HF study
Transition study and Pioneer HF studyTransition study and Pioneer HF study
Transition study and Pioneer HF studyEdgardo Kaplinsky
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Praveen Nagula
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...vaibhavyawalkar
 
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav YawalkarHeart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkarvaibhavyawalkar
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFDuke Heart
 
Acc 2018 guidelines on lipids
Acc 2018 guidelines on lipidsAcc 2018 guidelines on lipids
Acc 2018 guidelines on lipidsDr Anu Grover
 
2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertensionJulfikar Saif
 

What's hot (20)

His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...
His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...
His bundle pacing by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interv...
 
Beta blockers for heart failure
Beta blockers for heart failureBeta blockers for heart failure
Beta blockers for heart failure
 
HF Review
HF ReviewHF Review
HF Review
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEF
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approachDyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approach
 
2023 AHAACC Guideline.pptx
2023 AHAACC Guideline.pptx2023 AHAACC Guideline.pptx
2023 AHAACC Guideline.pptx
 
CONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTSCONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTS
 
Transition study and Pioneer HF study
Transition study and Pioneer HF studyTransition study and Pioneer HF study
Transition study and Pioneer HF study
 
SIGNIFY TRIAL
SIGNIFY TRIALSIGNIFY TRIAL
SIGNIFY TRIAL
 
Heart failure management - role of arni
Heart failure management - role of arniHeart failure management - role of arni
Heart failure management - role of arni
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
 
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav YawalkarHeart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
 
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
 
SGLT2 inhibitors
SGLT2 inhibitorsSGLT2 inhibitors
SGLT2 inhibitors
 
Acc 2018 guidelines on lipids
Acc 2018 guidelines on lipidsAcc 2018 guidelines on lipids
Acc 2018 guidelines on lipids
 
2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension2018 ESC/ESH Guidelines for the management of arterial hypertension
2018 ESC/ESH Guidelines for the management of arterial hypertension
 

Similar to 2019 ACC/AHA Primary Prevention Guidelines

2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-preventionPHAM HUU THAI
 
2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.pptHimaniPandya16
 
2019 cardio vascular disease prevention-guidelines
2019 cardio vascular disease  prevention-guidelines 2019 cardio vascular disease  prevention-guidelines
2019 cardio vascular disease prevention-guidelines DIPAK PATADE
 
Lec 6 preventive cardiology for mohs
Lec 6  preventive cardiology for mohsLec 6  preventive cardiology for mohs
Lec 6 preventive cardiology for mohsEhealthMoHS
 
C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015Diabetes for all
 
C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15Diabetes for all
 
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga
 
C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15Diabetes for all
 
ESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptxESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptxAshfakAlArifShuvon
 
preventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disorderspreventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disordersBaqer Aliraqi
 
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ingSalon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ingtyfngnc
 
Management of diabetes in elderly
Management of diabetes in elderlyManagement of diabetes in elderly
Management of diabetes in elderlyAditya Sarin
 
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...Dr Ranjit Jagtap
 
Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...Aditi Jagtap Pune
 
Highlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes managementHighlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes managementAhmed Elmoughazy
 
SOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from studentsSOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from studentsYajjatGarg
 

Similar to 2019 ACC/AHA Primary Prevention Guidelines (20)

2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention
 
2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt2019-Prevention-Guideline-Slides-gl-prevention.ppt
2019-Prevention-Guideline-Slides-gl-prevention.ppt
 
2019 cardio vascular disease prevention-guidelines
2019 cardio vascular disease  prevention-guidelines 2019 cardio vascular disease  prevention-guidelines
2019 cardio vascular disease prevention-guidelines
 
Diabetes and elderly
Diabetes and elderlyDiabetes and elderly
Diabetes and elderly
 
Lec 6 preventive cardiology for mohs
Lec 6  preventive cardiology for mohsLec 6  preventive cardiology for mohs
Lec 6 preventive cardiology for mohs
 
ADA '23 old pt-f&f.pptx
ADA '23 old pt-f&f.pptxADA '23 old pt-f&f.pptx
ADA '23 old pt-f&f.pptx
 
C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015C1 cda cpg quick reference guide update 2015
C1 cda cpg quick reference guide update 2015
 
C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15C2 aus general practice management of type 2 diabetes 2014 15
C2 aus general practice management of type 2 diabetes 2014 15
 
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And DiabetesDr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
Dr Vivek Baliga - Chronic Disease Management In Heart Failure And Diabetes
 
C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15C2 aus g practice management of diabetes 2014 15
C2 aus g practice management of diabetes 2014 15
 
ESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptxESC guideline for CVD prevention 2021..pptx
ESC guideline for CVD prevention 2021..pptx
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
preventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disorderspreventation of-coronary-vascular-disorders
preventation of-coronary-vascular-disorders
 
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ingSalon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
Salon 2 13 kasim 14.00 15.00 serpi̇l akkuş topçu-ing
 
Management of diabetes in elderly
Management of diabetes in elderlyManagement of diabetes in elderly
Management of diabetes in elderly
 
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
Importance of regular check-ups and screening for heart patients — Dr. Ranjit...
 
Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...Importance of regular check-ups and screening for heart patients — Aditi Jagt...
Importance of regular check-ups and screening for heart patients — Aditi Jagt...
 
Highlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes managementHighlights of ADA guidelines 2015 in Diabetes management
Highlights of ADA guidelines 2015 in Diabetes management
 
BSN Capstone Project Examples
BSN Capstone Project ExamplesBSN Capstone Project Examples
BSN Capstone Project Examples
 
SOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from studentsSOCIAL MEDICINE – TERM PAPER.pptx from students
SOCIAL MEDICINE – TERM PAPER.pptx from students
 

More from Sociedad Española de Cardiología

Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...Sociedad Española de Cardiología
 
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisiránePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisiránSociedad Española de Cardiología
 

More from Sociedad Española de Cardiología (20)

Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
Proyecto FARO. Prevención secundaria de la enfermedad cardiovascular ateroscl...
 
Estudio IVUS-ACS
Estudio IVUS-ACSEstudio IVUS-ACS
Estudio IVUS-ACS
 
Estudio PREVENT
Estudio PREVENTEstudio PREVENT
Estudio PREVENT
 
Estudio DEDICATE-DZHK6
Estudio DEDICATE-DZHK6Estudio DEDICATE-DZHK6
Estudio DEDICATE-DZHK6
 
Estudio TRAVERSE
Estudio TRAVERSEEstudio TRAVERSE
Estudio TRAVERSE
 
Estudio FULL-REVASC
Estudio FULL-REVASCEstudio FULL-REVASC
Estudio FULL-REVASC
 
Estudio IMPROVE-HCM
Estudio IMPROVE-HCMEstudio IMPROVE-HCM
Estudio IMPROVE-HCM
 
Estudio ORBITA-COSMIC
Estudio ORBITA-COSMICEstudio ORBITA-COSMIC
Estudio ORBITA-COSMIC
 
Estudio ARISE-HF
Estudio ARISE-HFEstudio ARISE-HF
Estudio ARISE-HF
 
Estudio TACTiC
Estudio TACTiCEstudio TACTiC
Estudio TACTiC
 
Estudio ULTIMATE DAPT
Estudio ULTIMATE DAPTEstudio ULTIMATE DAPT
Estudio ULTIMATE DAPT
 
Estudio SHASTA-2
Estudio SHASTA-2Estudio SHASTA-2
Estudio SHASTA-2
 
Estudio MINT
Estudio MINTEstudio MINT
Estudio MINT
 
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisiránePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
ePóster. Reducciones c-LDL el primer año de tratamiento con inclisirán
 
Estudio SMART
Estudio SMARTEstudio SMART
Estudio SMART
 
Estudio REDUCE-AMI
Estudio REDUCE-AMIEstudio REDUCE-AMI
Estudio REDUCE-AMI
 
Estudio DANGER
Estudio DANGEREstudio DANGER
Estudio DANGER
 
Estudio Liberate-HR
Estudio Liberate-HREstudio Liberate-HR
Estudio Liberate-HR
 
Estudio TELE-ACS
Estudio TELE-ACSEstudio TELE-ACS
Estudio TELE-ACS
 
BRIDGE-TIMI-73a
BRIDGE-TIMI-73aBRIDGE-TIMI-73a
BRIDGE-TIMI-73a
 

Recently uploaded

Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptxRajatChauhan518211
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡anilsa9823
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...ssifa0344
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptMAESTRELLAMesa2
 

Recently uploaded (20)

Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptx
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.ppt
 

2019 ACC/AHA Primary Prevention Guidelines

  • 1. Guías prevención CV Alberto Esteban Fernández 2019 ACC/ AHA GUIDELINE ON THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
  • 2. Guías prevención CV Alberto Esteban Fernández
  • 3. Guías prevención CV Alberto Esteban Fernández Top 10 Take – Home Messages for the Primary Prevention of Cardiovascular Disease
  • 4. Guías prevención CV Alberto Esteban Fernández 1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based care approach is an effective strategy for the prevention of cardiovascular disease. Clinicians should evaluate the social determinants of health that affect individuals to inform treatment decisions. 3. Adults who are 40 to 75 years of age and are being evaluated for cardiovascular disease prevention should undergo 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation and have a clinician–patient risk discussion before starting on pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In addition, assessing for other risk-enhancing factors can help guide decisions about preventive interventions in select individuals, as can coronary artery calcium scanning.
  • 5. Guías prevención CV Alberto Esteban Fernández 4. All adults should consume a healthy diet that emphasizes the intake of vegetables, fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the intake of trans fats, processed meats, refined carbohydrates, and sweetened beverages. For adults with overweight and obesity, counseling and caloric restriction are recommended for achieving and maintaining weight loss. 5. Adults should engage in at least 150 minutes per week of accumulated moderate- intensity physical activity or 75 minutes per week of vigorous-intensity physical activity. 6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary habits and achieving exercise recommendations, are crucial. If medication is indicated, metformin is first-line therapy, followed by consideration of a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist.
  • 6. Guías prevención CV Alberto Esteban Fernández 7. All adults should be assessed at every healthcare visit for tobacco use, and those who use tobacco should be assisted and strongly advised to quit. 8. Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit. 9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated lowdensity lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion. 10. Nonpharmacological interventions are recommended for all adults with elevated blood pressure or hypertension. For those requiring pharmacological therapy, the target blood pressure should generally be <130/80 mm Hg.